Brief: Consun Pharmaceutical FY Profit Attributable Rises 18.3%
March 23 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.2 PER SHARE
* FY PROFIT ATTRIBUTABLE RMB590.2 MILLION, INCREASE OF 18.3%
* REVENUE FOR YEAR RMB2.04 BILLION, UP ABOUT 16.6%
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director